Ledger.Open graph →
SEC Form D · Amendment · filed February 18, 2022

Balanced Pharma Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CORNELIUS, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

John S. Keadle · Cornelius, NCExec · DirectorJohn S. Selig · Cornelius, NCDirectorCastleKnight Management LP · New York, NYExec · DirectorCastleKnight Fund GP LLC · New York, NYDirectorRyan Tseng · San Diego, CAExec · DirectorMatthew Brawner · North St. Paul, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗